ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways

Zhang, Jinglin; Chen, Bonan; Li, Hui; Wang, Yifei; Liu, Xiaoli; Wong, Kit Yee; Chan, Wai Nok; Chan, Aden K. Y.; Cheung, Alvin H. k; Leung, Kam Tong; Dong, Yujuan; Pan, Yi; Ke, Huixing; Liang, Li; Zhou, Zhaocai; Xiao, Jianyong; Wong, Chi Chun; Wu, William K. K.; Cheng, Alfred S. L.; Ma, Brigette B. Y.; Yu, Jun; Lo, Kwok Wai; Kang, Wei*; To, Ka Fai*复旦大学; 广州中医药大学; 南方医科大学; 中国医学科学院; 中国医学科学院北京协和医院
Journal of Pathology2023-2DOI: 10.1002/path.6033
11被引16阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is one of the most common cancers worldwide. The tumor microenvironment exerts crucial effects in driving CRC progression. Cancer-associated fibroblasts (CAFs) serve as one of the most important tumor microenvironment components promoting CRC progression. This study aimed to elucidate the novel molecular mechanisms of CAF-secreted insulin-like growth factor (IGF) 2 in colorectal carcinogenesis. Our results indicated that IGF2 was a prominent factor upregulated in CAFs compared with normal fibroblasts. CAF-derived conditioned media (CM) promoted tumor growth, migration, and invasion of HCT 116 and DLD-1 cells. IGF1R expression is significantly increased in CRC, serving as a potent receptor in response to IGF2 stimulation and predicting unfavorable outcomes for CRC patients. Apart from the PI3K-AKT pathway, RNA-seq analysis revealed that the YAP1-target signature serves as a prominent downstream effector to mediate the oncogenic signaling of IGF2-IGF1R. By single-cell RNA sequencing (scRNA-seq) and immunohistochemical validation, IGF2 was found to be predominantly secreted by CAFs, whereas IGF1R was expressed mainly by cancer cells. IGF2 triggers the nuclear accumulation of YAP1 and upregulates YAP1 target signatures; however, these effects were abolished by either IGF1R knockdown or inhibition with picropodophyllin (PPP), an IGF1R inhibitor. Using CRC organoid and in vivo studies, we found that cotargeting IGF1R and YAP1 with PPP and verteporfin (VP), a YAP1 inhibitor, enhanced antitumor effects compared with PPP treatment alone. In conclusion, this study revealed a novel molecular mechanism by which CAFs promote CRC progression. The findings highlight the translational potential of the IGF2-IGF1R-YAP1 axis as a prognostic biomarker and therapeutic target for CRC.

学科与关键词

关键词
cancer-associated fibroblastscolorectal cancerIGF2IGF1RHippo-YAP1 signaling pathway
相关
加载中…
  • Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer.
    Ou, Chunlin; Sun, Zhenqiang; He, Xiaoyun; Li, Xiaoling; Fan, Songqing; Zheng, Xiang; Peng, Qiu; Li, Guiyuan; Li, Xiayu; Ma, JianAdv Sci (Weinh), 2020, 7(3): 1901380.被引 73
  • MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer.
    Ou, Chunlin; Sun, Zhenqiang; Li, Xiayu; Li, Xiaoling; Ren, Weiguo; Qin, Zailong; Zhang, Xuemei; Yuan, Weitang; Wang, Jia; Yu, Wentao; Zhang, Shiwen; Peng, Qiu; Yan, Qun; Xiong, Wei; Li, Guiyuan*; Ma, Jian*Cancer Letters, 2017, 399: 53-63.
  • Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses
    Wang, Yan; Chen, Zhengbo; Zhao, Gang; Li, Qiang*Mediators of Inflammation, 2023, 2023: 3781091.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Pathology
发表日期
2023-02
卷期
第 259 卷, 第 2 期
页码
205-219
DOI
10.1002/path.6033
语言
ENGLISH
成果收录
SCIE
资助标注
Research Grants Council of the Hong Kong Special Administrative Region, China (GRF Project) [81871900]; National Natural Science Foundation of China (NSFC) [81871900, 81903019, 82272990]; Comprehensive Precision Oncology Program at the Chinese University of Hong Kong

作者

  • Z

    Zhang, Jinglin (第一作者)

    chinese univ hong kong

  • C

    Chen, Bonan

    chinese univ hong kong

查看全部 24 位作者收起作者
  • L

    Li, Hui

    chinese univ hong kong

  • W

    Wang, Yifei

    chinese univ hong kong

  • L

    Liu, Xiaoli

    chinese univ hong kong

  • W

    Wong, Kit Yee

    chinese univ hong kong

  • C

    Chan, Wai Nok

    chinese univ hong kong

  • C

    Chan, Aden K. Y.

    chinese univ hong kong

  • C

    Cheung, Alvin H. k

    chinese univ hong kong

  • L

    Leung, Kam Tong

    chinese univ hong kong

  • D

    Dong, Yujuan

    chinese univ hong kong

  • P

    Pan, Yi

    chinese acad med sci · peking union med coll

  • K

    Ke, Huixing

  • L

    Liang, Li

    southern med univ

  • Z

    Zhou, Zhaocai

    fudan univ

  • X

    Xiao, Jianyong

    guangzhou univ chinese med

  • W

    Wong, Chi Chun

    chinese univ hong kong

  • W

    Wu, William K. K.

    chinese univ hong kong

  • C

    Cheng, Alfred S. L.

    chinese univ hong kong

  • M

    Ma, Brigette B. Y.

    chinese univ hong kong

  • Y

    Yu, Jun

    chinese univ hong kong

  • L

    Lo, Kwok Wai

    chinese univ hong kong

  • K

    Kang, Wei (通讯)

    chinese univ hong kong

  • T

    To, Ka Fai (通讯)

    chinese univ hong kong

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417